KalVista Pharmaceuticals, Inc. (KALV)

14.89 -0.05 (-0.33%) USD  |  NASDAQ  |  Jan 14, 10:15
More

KalVista Pharmaceuticals Change in Receivables (TTM)

Change in Receivables (TTM) Chart

View Change in Receivables (TTM) for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Receivables (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Receivables (TTM) Range, Past 5 Years

View Change in Receivables (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Receivables (TTM) Benchmarks

View Change in Receivables (TTM) Benchmarks
Start Trial
BioCryst Pharmaceuticals, Inc. Upgrade
Silvergate Capital Corp. --
Perspective Therapeutics, Inc. Upgrade
Electromed, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade